Dexcom partners with diabetes pump maker for its forthcoming smartphone app

By Aditi Pai
Share
Dexcom Dexcom Guide, the company's current education-only app

Continuous glucose monitor maker Dexcom announced that it will partner with insulin pump maker Silicon Valley-based Asante Solutions so that users of Asante devices will be able to access that data from Dexcom's not-yet launched smartphone app.

Dexcom already offers one app that helps people with diabetes watch training videos, read educational materials on diabetes care, and look at a pictorial of how to insert its sensor, but has plans to launch a second that aggregates diabetes-related data, like glucose, from different devices.

“More than ever, we believe that effective diabetes management depends on timely and accurate data," Dexcom Chief Operating Officer Kevin Sayer said in a statement. "That is why we are excited to complete development of our mobile app and integrate data from the Asante Snap Insulin Pump system."

This is the second insulin pump company that has partnered with Dexcom for its upcoming app. The first was Insulet Corporation's OmniPod. At the time Dexcom also announced that they planned to take an "open architecture" approach to data integration from diabetes-related devices. All devices and apps that partner with Dexcom integrate data into the company's forthcoming app will have an “approved by Dexcom” logo on them.

It's also possible that the app will eventually integrate data from a connected Dexcom device.

In January, Dexcom filed for a patent for a system that would integrate a smartphone with a Dexcom device. Much of the functionality described in the patent has to do with collecting continuous blood sugar data and other data — like activity and location — simultaneously, so the user can retrospectively see what sorts of life events tend to lead to hypo- and hyperglycemic events. But the patent also suggests that the device might be able to take action in cases of low blood sugar.

In June, Dexcom was the first launch partner for Joslin Diabetes Center's new non-profit division, called Joslin Institute for Technology Translation (JITT). The new division was created so that the healthcare organization can collaborate with companies currently developing tools for people with diabetes.